Attenuation Imaging in Hepatic Steatosis

NCT05302258 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-03-31

No results posted yet for this study

Summary

For obese and normal-weight children, the investigators assess the diagnostic performance of attenuation imaging (ATI) in the detection of hepatic steatosis in children.

Conditions

  • Hepatic Steatosis
  • Obesity, Childhood
  • Ultrasonography

Interventions

DIAGNOSTIC_TEST

Attenuation imaging in ultrasonography

Attenuation imaging in ultrasonography

Sponsors & Collaborators

  • Hallym University Kangnam Sacred Heart Hospital

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-14
Primary Completion
2022-12-14
Completion
2022-12-14

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302258 on ClinicalTrials.gov